journal article·2025-08Open access

Gold nanoparticle-loaded macrophages enhance radiotherapy via immune remodeling in oral cancer

Hui-Wen Chan, Pei-Wei Sheung, Stella Tzu-Ming Tsao, Chun-Yi Wu, Hui-Yen Chuang

Abstract

: Gold nanoparticles (GNPs) are promising radiosensitizers owing to their high atomic number, but their therapeutic efficacy is often limited by reticuloendothelial system (RES)-mediated clearance and poor tumor accumulation attributable to elevated interstitial fluid pressure. This study explored macrophage-mediated GNP delivery to enhance radiotherapy (RT) efficacy in oral cancer by leveraging the tumor-homing ability, immune plasticity, hypoxia tropism, and RES evasiveness of macrophages. Murine oral cancer cells (MCTQ1) and macrophages (RAW 264.7) were used. GNPs were synthesized using the Turkevich method, which were then assessed for radiosensitization using cell viability and colony formation assays. GNPs were radiolabeled with Iodine-131 ( 131 I) using the chloramine-T method, and uptake by RAW 264.7 cells was quantified at various time points to optimize the generation of GNP-loaded macrophages (GNP@Rs). MTCQ1 tumor-bearing mice were divided into control, RT, GNP, RAW, GNP + RT, RAW + RT, and GNP@R + RT groups. Tumor volumes were monitored after GNP or cell administration and/or RT (8 Gy). Flow cytometry was used to analyze the immune cell populations post-treatment. Transwell assays confirmed that GNP loading did not impair macrophage migration, and in vivo fluorescence imaging demonstrated strong tumor tropism of RAW 264.7 cells and GNP@Rs. GNP@Rs maintained their migration ability and exhibited robust tumor accumulation for up to 96 hours. Notably, GNP@R + RT treatment significantly enhanced tumor suppression relative to RT alone and increased the infiltration of macrophages, activated dendritic cells, CD4 + and CD8 + T cells, and natural killer cells. Macrophage-mediated GNP delivery successfully improved RT outcomes in oral cancer by increasing radiosensitivity and modulating immune microenvironment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (58)

Show source-provided references
1. Radiotherapy and theranostics: a lancet oncology commission10.1016/S1470-2045(24)00407-8 ↗
2. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer10.1038/s41392-020-0150-x ↗
3. Increased expression of pAKT is associated with radiation resistance in cervical cancer10.1038/sj.bjc.6603180 ↗
4. Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells10.1016/j.redox.2019.101189 ↗
5. Inhibition of EGFR abrogates radioresistance in human oral cancer by inhibiting the endoplasmic reticulum stress chaperone GRP7810.1016/j.ijrobp.2018.07.694 ↗
6. Tumor microenvironment and radioresistance10.1038/s12276-021-00640-9 ↗
7. Significance of HIF-1-active cells in angiogenesis and radioresistance10.1038/sj.onc.1210556 ↗
8. Radiation-induced tumor immune microenvironments and potential targets for combination therapy10.1038/s41392-023-01462-z ↗
9. Roadmap to clinical use of gold nanoparticles for radiation sensitization10.1016/j.ijrobp.2015.09.032 ↗
10. Application of High-Z nanoparticles to enhance current radiotherapy treatment10.3390/molecules29112438 ↗
11. Inhibition of key DNA double strand break repair protein kinases enhances radiosensitivity of head and neck cancer cells to X-ray and proton irradiation10.1038/s41420-024-02059-3 ↗
12. Tumour reoxygenation after intratumoural hydrogen peroxide (KORTUC) injection: a novel approach to enhance radiosensitivity10.1038/s44276-024-00098-y ↗
13. Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme10.1186/s12951-020-00684-5 ↗
14. Radiotherapy for anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration10.1016/S0140-6736(24)00915-2 ↗
15. Radiosensitivity is associated with antitumor immunity in estrogen receptor-negative breast cancer10.1007/s10549-022-06818-7 ↗
16. Physical basis and biological mechanisms of gold nanoparticle radiosensitization10.1039/c2nr31227a ↗
17. Simulation on the molecular radiosensitization effect of gold nanoparticles in cells irradiated by x-rays10.1088/0031-9155/60/16/6195 ↗
18. Intercomparison of radiosensitization induced by gold and iron oxide nanoparticles in human glioblastoma cells irradiated by 6 MV photons10.1038/s41598-022-13368-x ↗
19. Shape-dependent radiosensitization effect of gold nanostructures in cancer radiotherapy: Comparison of gold nanoparticles, nanospikes, and nanorods10.1021/acsami.7b01112 ↗
20. Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles10.1186/s13014-021-01751-3 ↗
21. Development of sialic acid-coated nanoparticles for targeting cancer and efficient evasion of the immune system10.7150/thno.19061 ↗
22. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy
23. Nanoparticle uptake in tumors is mediated by the interplay of vascular and collagen density with interstitial pressure10.1016/j.nano.2012.07.002 ↗
24. Overcoming the reticuloendothelial system barrier to drug delivery with a "Don't-Eat-Us" Ssrategy10.1021/acsnano.9b05679 ↗
25. Mediating tumor targeting efficiency of nanoparticles through design10.1021/nl900031y ↗
26. Cell-mediated nanoparticle delivery systems: towards precision nanomedicine10.1007/s13346-024-01591-0 ↗
27. Cell-based drug delivery systems and their in vivo fate10.1016/j.addr.2022.114394 ↗
28. Cell-based drug delivery systems with innate homing capability as a novel nanocarrier platform10.2147/IJN.S394389 ↗
29. Phagocytosis: our current understanding of a universal biological process10.3389/fimmu.2020.01066 ↗
30. The portrayal of macrophages as tools and targets: a paradigm shift in cancer management10.1016/j.lfs.2023.121399 ↗
31. Tumor-associated macrophages: an accomplice in solid tumor progression10.1186/s12929-019-0568-z ↗
32. Hypoxia regulates macrophage functions in inflammation10.4049/jimmunol.175.10.6257 ↗
33. Turkevich method for gold nanoparticle synthesis revisited10.1021/jp061667w ↗
34. Au/ZnO nanocomposites prepared by laser ablation for enhancement of antibacterial activity and cytotoxic properties against cancer cells10.3390/met13040735 ↗
35. Iodine-Labeled Au Nanorods with High Radiochemical Stability for Imaging-Guided Radiotherapy and Photothermal Therapy10.1021/acsanm.8b02229 ↗
36. Synthesis of precision gold nanoparticles using turkevich method10.14356/kona.2020011 ↗
37. Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment10.1021/nn202155y ↗
38. Determining the size and shape dependence of gold nanoparticle uptake into Mammalian cells10.1021/nl052396o ↗
39. Gold nanoparticles as radiation sensitizers in cancer therapy10.1667/RR1984.1 ↗
40. Macrophages as promising carriers for nanoparticle delivery in anticancer therapy10.2147/IJN.S421173 ↗
41. Macrophages-mediated delivery of small gold nanorods for tumor hypoxia photoacoustic imaging and enhanced photothermal therapy10.1021/acsami.9b00495 ↗
42. Tumor-associated macrophages in tumor immunity10.3389/fimmu.2020.583084 ↗
43. Macrophage polarization in the tumor microenvironment: emerging roles and therapeutic potentials10.1016/j.biopha.2024.116930 ↗
44. M1/M2 macrophages and their overlaps - myth or reality?10.1042/CS20220531 ↗
45. Structure and function of the immune system in the spleen10.1126/sciimmunol.aau6085 ↗
46. A four-part guide to lung immunology: invasion, inflammation, immunity, and intervention10.3389/fimmu.2023.1119564 ↗
47. Liver immunity, autoimmunity, and inborn errors of immunity10.4254/wjh.v15.i1.52 ↗
48. Macrophage-mediated delivery of magnetic nanoparticles for enhanced magnetic resonance imaging and magnetothermal therapy of solid tumors10.1016/j.jcis.2022.08.186 ↗
49. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence10.1038/nrc3958 ↗
50. Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy10.1038/s41590-020-0751-0 ↗
51. Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL810.1126/sciadv.abh4050 ↗
52. Immunomodulation of NK cells by ionizing radiation10.3389/fonc.2020.00874 ↗
53. Lymphatic system regulation of anti-cancer immunity and metastasis10.3389/fimmu.2024.1449291 ↗
54. Natural killer cells at the frontline in the fight against cancer10.1038/s41419-024-06976-0 ↗
55. T cells, NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems
56. Priming of human resting NK cells by autologous M1 macrophages via the engagement of IL-1beta, IFN-beta, and IL-15 pathways10.4049/jimmunol.1500325 ↗
57. Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC10.1007/s00262-020-02792-5 ↗
58. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming10.1038/ni1138 ↗